![conference banner](/images/conference-banner.jpeg)
Abstract
The craniofacial region contains many specified tissues, including bone, cartilage, muscle, blood vessels, fat, skin and neurons. A defect or dysfunction of the craniofacial tissue after post-cancer ablative surgery, trauma, congenital malformations and progressive deforming skeletal diseases has a huge influence on the patient’s life. Therefore, functional reconstruction of damaged tissues is highly sought. The use of cell-based therapies represents one of the most advanced methods for enhancing the regenerative response for craniofacial wound-healing. The recently acquired ability to reprogram human adult somatic cells to induced pluripotent stem cells (iPSCs) in culture may provide a powerful tool for in vitro disease modeling and an unlimited source for cell replacement therapy. This review focuses on the generation, biological characterization and discussion of the potential application of iPSCs for craniofacial tissue-engineering applications.
Keywords: Cell differentiation, craniofacial reconstruction, embryonic stem cells, induced pluripotent stem cells, regenerative medicine, somatic cells.
Current Stem Cell Research & Therapy
Title:Potential Replication of Induced Pluripotent Stem Cells for Craniofacial Reconstruction
Volume: 9 Issue: 3
Author(s): Yao Fu, Shuwen Deng, Jing Wang, Zhaozhao Chen, Shu Zhang, Songtao Wu, Yan Jiang, Ling Ye, Qiang Peng and Yunfeng Lin
Affiliation:
Keywords: Cell differentiation, craniofacial reconstruction, embryonic stem cells, induced pluripotent stem cells, regenerative medicine, somatic cells.
Abstract: The craniofacial region contains many specified tissues, including bone, cartilage, muscle, blood vessels, fat, skin and neurons. A defect or dysfunction of the craniofacial tissue after post-cancer ablative surgery, trauma, congenital malformations and progressive deforming skeletal diseases has a huge influence on the patient’s life. Therefore, functional reconstruction of damaged tissues is highly sought. The use of cell-based therapies represents one of the most advanced methods for enhancing the regenerative response for craniofacial wound-healing. The recently acquired ability to reprogram human adult somatic cells to induced pluripotent stem cells (iPSCs) in culture may provide a powerful tool for in vitro disease modeling and an unlimited source for cell replacement therapy. This review focuses on the generation, biological characterization and discussion of the potential application of iPSCs for craniofacial tissue-engineering applications.
Export Options
About this article
Cite this article as:
Fu Yao, Deng Shuwen, Wang Jing, Chen Zhaozhao, Zhang Shu, Wu Songtao, Jiang Yan, Ye Ling, Peng Qiang and Lin Yunfeng, Potential Replication of Induced Pluripotent Stem Cells for Craniofacial Reconstruction, Current Stem Cell Research & Therapy 2014; 9 (3) . https://dx.doi.org/10.2174/1574888X09666140213155800
DOI https://dx.doi.org/10.2174/1574888X09666140213155800 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Common Genetic Conditions of Ischemic Stroke to Keep in Mind
Current Molecular Medicine Role of Azoles in Cancer Prevention and Treatment: Present and Future Perspectives
Anti-Cancer Agents in Medicinal Chemistry Mitral Valve Prolapse and Sudden Cardiac Death in Athletes at High Risk
Current Cardiology Reviews Infection, Infectious Agents and Vascular Disease
Reviews on Recent Clinical Trials Clinical Applications of Cardiovascular Magnetic Resonance
Current Pharmaceutical Design Recent Patents Relating to siRNAs and Therapeutic Strategies for Genetic Diseases
Recent Patents on DNA & Gene Sequences Endovascular Repair of Thoracic Aortic Aneurysms
Recent Patents on Cardiovascular Drug Discovery Targeting Fibrosis in Systemic Sclerosis
Endocrine, Metabolic & Immune Disorders - Drug Targets Pathogenesis of Alcohol-Induced Osteoporosis and its Treatment: A Review
Current Drug Targets Climate Change, Climate Variability and Brucellosis
Recent Patents on Anti-Infective Drug Discovery Arrhythmias and Left Ventricular Hypertrabeculation/Noncompaction
Current Pharmaceutical Design Identification of Candidate Biomarkers of Acute Aortic Dissection
Recent Patents on DNA & Gene Sequences Management of Incidental Findings in the Era of Next-generation Sequencing
Current Genomics Quantitative Ultrasound in Diagnosis of Metabolic Bone Diseases
Current Medical Imaging Cardiovascular Diseases in Pregnancy - A Brief Overview
Current Cardiology Reviews Marfan Syndrome and Related Heritable Thoracic Aortic Aneurysms and Dissections
Current Pharmaceutical Design Current Genomics in Cardiovascular Medicine
Current Genomics Microhomology-Mediated Break-Induced Replication: A Possible Molecular Mechanism of the Formation of a Large CNV in <i>FBN1</i> Gene in a Patient with Marfan Syndrome
Current Molecular Medicine Novel Methods of Genetic Modification of Human Pluripotent Stem Cells
Recent Patents on Regenerative Medicine Evaluation of Anti-aging Compounds Using the Promoters of Elastin and Fibrillin-1 Genes Combined with a Secreted Alkaline Phosphatase Reporter in Normal Human Fibroblasts
Current Pharmaceutical Biotechnology